Default company panoramic image
Allysta 20logo 20rectangle 201

Allysta Pharmaceuticals, Inc.

Developing Novel Therapies for Eye Diseases

  • Stage Product In Development
  • Industry Biotechnology
  • Location Belmont, CA, US
  • Currency USD
  • Founded March 2013
  • Employees 5
  • Incorporation Type S-corp
  • Website allysta.com

Company Summary

Allysta Pharmaceuticals, Inc., is a privately-held biopharmaceutical company based in the San Francisco Bay Area with a focus in ophthalmology, particularly dry eye disease and glaucoma. We have developed a novel first-in-class approach to reducing the inflammation that drives dry eye disease that targets adiponectin. We are also developing a novel multi-kinase for glaucoma. We expect to enter clinical testing for both in 2018.

Team

  • 7eb940e2 896b 4a80 bc72 a407ecee27b2
    CEO and President

    Henry has over 25 years experience in all aspects of drug development in multiple therapeutic areas, with a particular interest in ocular diseases. He was a co-founder of Altheos, Inc., and raised more than $30 million. He has served as Chief Medical Officer at Plexxikon, Inc. He received his MD from the University of California, SF, and trained at Stanford Medical Center, where he was a Howard Hughes Physician Research Fellow.